Monday, 2 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Fund Raise

Sanchay Finvest Fund Raise of ₹4.85 Cr

Sanchay Finvest Ltd has allotted 48,50,000 equity shares at Rs. 10 per share on a preferential basis to five non-promoter allottees. The total capital raised through this issuance is ₹4.85 Crore. The board also cancelled a proposed allotment of 12,50,000 shares due to non-subscription.

Key figures
Value₹4.85 Cr
Source

BSE filing, NSE: SANCHAY. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Sanchay Finvest Ltd: key numbers

Share price
₹49.11
Market cap
₹39.29 Cr
Revenue (annual)
₹-0.02 Cr
Net profit (annual)
₹-1.41 Cr
P/E (TTM)
-27.4×Sector 19.8×
Promoter holding
23.50%+0.00% QoQ
FII holding
0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Sanchay Finvest Ltd

All →

Other fund raise announcements

All →
17:44 IST BSE
Fund RaiseU Y Fincorp Ltd UYFINCORP

U Y Fincorp Fund Raise of ₹187.2 Cr

U.Y. Fincorp's board approved preferential issues of warrants and equity shares aggregating Rs 187.17 Crore. The issue is subject to shareholder and regulatory approvals.

Value
₹187.2 Cr
20:28 IST BSE
Fund RaiseSudarshan Pharma Industries Ltd SUDARSHAN

Sudarshan Pharma Industries Fund Raise of ₹72 Cr

Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.

Value
₹72.00 Cr
19:27 IST NSE
Fund RaiseFlywings Simulator Training Centre Ltd FWSTC

Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr

Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.

Value
₹68.20 Cr
16:20 IST BSE
Fund RaiseKanel Industries Ltd KANELOIL

Kanel Industries Fund Raise of ₹16.99 Cr

Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.

Value
₹16.99 Cr
Execution
Rights issue opens 23 November 2026 and closes 30 November 2026
15:05 IST BSE
Fund RaiseSudarshan Pharma Industries Ltd SUDARSHAN

Sudarshan Pharma Industries Fund Raise

Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.